Psychiatric aspects of endocrine disorders in women.
Endocrine disorders are associated with significant psychiatric morbidity. Psychiatric symptoms may manifest as discreet psychiatric syndromes or, more commonly, with a heterogenous group of nonspecific symptoms. Research is needed to understand the relations between hormone excess or deficiency and alterations of mood, cognition, and perception. It is important for clinicians to carefully screen for psychiatric morbidity in patients who present with endocrine disorders. Moreover, patients who appear to present with primary psychiatric syndromes should be carefully evaluated by physical examination and biochemical screening when appropriate to exclude the presence of an underlying endocrine disorder.
Joffe
Russell T
RT
Department of Psychiatry, UMDNJ-New Jersey Medical School, 185 South Orange Avenue, MSB C-671, Newark, NJ 07103, USA. joffe@umdnj.edu
Brasch
Jennifer S
JS
MacQueen
Glenda M
GM
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D003480:Cushing Syndrome / Q000378:metabolism; D003920:Diabetes Mellitus / Q000378:metabolism; D004700:Endocrine System Diseases / Q000378:metabolism / Q000503:physiopathology* / Q000523:psychology*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D019382:Human Growth Hormone / Q000378:metabolism; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D007986:Luteinizing Hormone / Q000378:metabolism; D010279:Parathyroid Diseases / Q000378:metabolism; D010913:Pituitary-Adrenal System / Q000503:physiopathology*; D011388:Prolactin / Q000378:metabolism
D019382:Human Growth Hormone; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone